tiprankstipranks
Trending News
More News >

Robinhood - New Portfolio

JOSE RAMIREZ

Robinhood
Individual Investor
Ranked #133,747 out of 834,064 TipRanks' Investors
Success Rate
57%
104 out of 181
profitable transactions
Average Return
37.73%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 6.01%
6-Month Return▼ 1.55%
12-Month Return▲ 13.75%
YTD Return▲ 15.62%
Total Return▼ 9.40%

Best Trade

Opened at
Closed at-
Gain▲ 1084.44%

Bio

Compound Dividends Portfolio

Performance

18.95%0-18.95%
▲ 11.63%
▲ 6.28%
▲ 6.43%
May 2025
▲ 9.25%
▲ 5.14%
▲ 18.95%
Jun 2025
▲ 7.60%
▲ 2.30%
▼ 1.36%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 3.58%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 3.24%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 1.40%
Oct 2025
▼ 3.57%
▲ 0.19%
▼ 2.41%
Nov 2025
▲ 1.61%
▲ 1.31%
▼ 6.01%
Dec 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 11.63%▲ 6.28%▲ 6.43%
▲ 9.25%▲ 5.14%▲ 18.95%
▲ 7.60%▲ 2.30%▼ 1.36%
▲ 2.76%▲ 2.05%▲ 3.58%
▲ 12.88%▲ 3.56%▲ 3.24%
▲ 10.96%▲ 2.38%▲ 1.40%
▼ 3.57%▲ 0.19%▼ 2.41%
▲ 1.61%▲ 1.31%▼ 6.01%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Meta Platforms
0%
▼ 11.16%
1
Open
Aug 20, 2025
Alphabet Class A
1.44%
▲ 62.55%
2
Buy
Aug 04, 2025
Amazon
0%
▲ 2.22%
1
Open
Jul 22, 2025
Viracta Therapeutics
▼ 98.00%
4
Close
Jul 16, 2025
Direxion Daily S&P 500 Bull 3x Shares
23.2%
▲ 113.80%
8
Buy
Mar 29, 2025
Walt Disney
6.27%
▲ 15.16%
8
Buy
Mar 29, 2025
Coca-Cola
8.04%
▲ 20.97%
10
Buy
Mar 29, 2025
Kraft Heinz
2.78%
▼ 24.94%
12
Buy
Mar 29, 2025
Energy Transfer
9.72%
▲ 59.67%
15
Buy
Mar 29, 2025
AT&T
5.79%
▲ 51.52%
13
Buy
Mar 29, 2025
Bank of America
3.36%
▲ 78.49%
8
Buy
Mar 29, 2025
Pfizer
0.92%
▼ 8.91%
3
Buy
Mar 29, 2025
aTyr Pharma
0.92%
▼ 63.28%
8
Buy
Mar 29, 2025
Nvidia
6.14%
▲ 53.06%
3
Buy
Mar 29, 2025
Tempest Therapeutics
0.21%
▼ 75.34%
3
Buy
Mar 29, 2025
PDS Biotechnology
0.04%
▼ 24.03%
1
Open
Mar 29, 2025
Stronghold Digital Mining
▼ 97.39%
3
Close
Mar 14, 2025
Bitfarms
0.03%
▲ 123.42%
1
Open
Mar 14, 2025
Carisma Therapeutics
0.01%
▼ 98.50%
5
Buy
Oct 29, 2024
Viking Therapeutics
0.17%
▲ 632.59%
8
Sell
Oct 29, 2024